Methods and Analysis

13
We will search MEDLINE (Ovid) and EMBASE (Ovid) for studies describing human factors that affect 14 FTR and EOC. A search strategy was developed by two researchers assisted by a medical librarian. 15
Only studies exploring EOC in hospital ward populations using qualitative data collection methods 16 will be included. Screening will be conducted by two researchers from different professional 17 backgrounds. Selected studies will be assessed for quality, rigor and limitations. Two researchers will 18 extract and thematically synthesise codes using a piloted data extraction tool to develop analytical 19 themes. 20
Ethics and dissemination
21
This systematic review will use available published literature and therefore no ethical approval is 22 required. This systematic review will be limited by the quality of studies available and the rigor and 23 reproducibility of study findings. This review will synthesise what is known about human factors and 24 escalation of care, highlighting gaps within the literature. Results of this review will be published in 25 peer reviewed journal, presented at conferences and publicised on social media. 26
TRIAL REGISTRATION
PROSPERO: (CRD42018104745) 28
ARTICLE SUMMARY
29
Strengths and Limitations of this study 30
• FTR is a common and significant problem in healthcare which affects patient mortality 31
• For FTR to be avoided, an escalation of care needs to occur. This efficacy of this can be 32 positively or negatively affected by human factors 33
• This protocol ensures a comprehensive and unbiased search and analysis of qualitative 34 studies exploring this phenomenon using best practice guidelines 35
• The results of this review will identify strengths and weaknesses of the literature in this 36 area 37
• This review will highlight future research direction and address some of the identified 38 weaknesses 39 FTR is defined as the mortality rate of patients who suffer complications in hospital (1) . The 2 incidence of FTR varies between hospitals but has been estimated as 10.9% in high-volume hospitals 3 and 13.3% in low-volume hospitals. A proportion of patient deaths (32%) reported to the National 4
40
Patient Safety Agency (NSPA) had failures surrounding diagnostic errors and deteriorations which 5
were not adequately recognised (5). This theme is present in several national reports such as 6 National Confidential Enquiry into Patient Outcomes and Death (NCEPOD) (3,6-8) and NICE CG 50 7 (4). 8
For FTR to be avoided, bedside clinical staff must usually initiate successful escalation of care (EOC) 9 (9). This staged process requires detection of deterioration, communication about deterioration, and 10 medical actions following a senior review (3). Many factors affect this process such as situational 11 awareness, team working, communication, safety culture and leadership (3,10-14). Understanding 12 these human factors is essential to developing working systems that mitigate barriers and encourage 13 facilitation. 14 As a primary outcome, this qualitative systematic review will identify the human factors which affect 15 EOC in the acute hospital setting. It will summarise what is currently understood about the 16 involvement of human factors and their implications for practice. As a secondary outcome, it will 17 identify any gaps in the current literature and establish strengths and weaknesses of the research. 18
This will identify potential areas for further research in human factors and EOC. 19 20
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21
Registration 22
This protocol adheres to the requirements of Preferred Reporting Items for Systematic Review and 23
Meta-analysis Protocols (PRISMA-P). The protocol was registered with PROSPERO 24 (CRD42018104745) 25
Information sources 26
Literature search strategies will be developed using Medical Subject Headings (MeSH) and text 27 words related to the human factors involved in the escalation of care for deteriorating patients. 28
The following databases will be searched: MEDLINE (Ovid), EMBASE (Ovid). 29
Reference lists of eligible studies and relevant reviews will be explored to identify further eligible 30 studies. 31
Search strategy 32
A draft of the search strategy was developed by three of the authors (JE, VW and TP -a medical 33 librarian). The proposed search strategy is shown in the online Supplementary File 1. 34
Inclusion Criteria 35
Types of studies 36
This systematic review will include qualitative studies which report primary data. Qualitative studies 37 are defined as those studies which use qualitative data collection and analysis methods. These can 38 Data analysis is likely to be but not limited to: thematic analysis, grounded theory and discourse 2 analysis. 3
Phenomenon of interest 4
Studies must report primary data and describe the human factors which affect FTR and EOC. FTR is 5 defined as patient mortality following complications (1) and EOC is a staged process where patients 6 are detected as deteriorating and that deterioration is communicated followed by a senior review 7 (3). We will include any qualitative study which explores the perspective of patients or clinical staff 8 (adults or paediatric) and the human factors which affect the EOC process. We are defining human 9 factors as any barrier or facilitator that affects teamwork, tasks, equipment, workspace, culture and 10 organisation (15). 11
Setting
12
The study setting is in-hospital, ward care. 13
Exclusion criteria 14
Types of studies 15 We will exclude systematic reviews, grey-literature, editorials, letters, practice guidelines and 16 abstract-only reports. We will also exclude protocols without study data. 17 18
Phenomenon of interest 19
We are only interested in real-life scenarios where human factors effects can be studied in the 20 patient environment. Simulation based studies will be excluded. 21
Setting
22
We will exclude studies carried out in the Emergency Department, Critical Care (including the 23
Intensive Care Unit and Coronary care) or Maternity. These are specialised areas which makes 24 generalisability of EOC themes to the ward environment challenging. We will also exclude studies 25 set in palliative care. 26
Time-frame 27
No time limitations will be applied 28
Language
29
Non-English papers will be excluded. 30
Study selection 31
Reference lists from both databases will be entered into Covidence software (Covidence systematic  32 review software, Veritas Health Innovation, Melbourne, Australia. Available at www.covidence.org). 33
Papers will be de-duplicated. Two authors will independently screen titles and abstracts of identified 34 papers against the inclusion and exclusion criteria. They will not be blinded to journal titles, study 35 authors or institutions. If there is disagreement or uncertainty regarding eligibility, the full-text will 36 be reviewed. We will retrieve full-text for all articles not excluded by the initial screening. Two 37 authors will independently assess these papers against the inclusion and exclusion criteria outlined 38 above. We will resolve disagreements about eligibility by discussion between the screening 39 researchers or a third party. We will record the reason for excluding studies. 40
Data extraction
Data extraction tools will be developed and piloted before the review takes place. Extracted data will 1 be entered into an Excel spreadsheet. Initial codes from studies will be documented with NVivo 2
[NVivo qualitative data analysis Software; QSR International Pty Ltd. Version 10, 2014]. Two 3 reviewers will independently extract a selection data from the texts to ensure validity of results. Any 4 discrepancies within the data collection phase will be resolved by discussion between reviewers. 5
Data items extracted 6
We will extract the following data from each included publication. The data extraction method has 7 been piloted with a sample selection of papers and valid data has been obtained. 8 
Quality Assessment 11
The CASP qualitative checklist (Critical Appraisal Skills Programme) will be used to assess credibility, 12 transferability, dependability and confirmability. This checklist is an extensive and comprehensive 13 tool commonly used in qualitative study assessment (16, 17) . Two researchers will discuss quality 14 findings for each study and a consensus will be reached as to the studies' inclusion or exclusion 15 within the systematic review. As part of the CASP assessment the authors will explore the potential 16 for reporting bias within the studies and biases will be reported in studies' limitations. 17
Data Analysis 18
We will undertake a thematic synthesis (17) using the Thomas and Harden (18) framework. The 19 three stages of the framework are: coding of the findings of studies, categorisation of codes into 20 descriptive themes, and categorisation of descriptive themes into analytical themes (19). NVivo 21 software will be used to facilitate the analysis and record decisions (audit trail) of coding by the 22 researchers. Codes relating to human factors and EOC will be identified in the text, and tables will be 23 used to create descriptive and analytical themes. Key codes, descriptive themes and analytical 24 themes will be presented in the results. 25
Ethics and dissemination
26
The proposed systematic review will use available published literature and therefore no ethical 27 approval is required. This systematic review will be limited by the quality of studies available and the 28 rigor and reproducibility of study findings. Original studies included in the review could themselves 29 be limited and it may be difficult to assess the researcher involvement and their individual bias. The 30 F o r p e e r r e v i e w o n l y 6 two researchers carrying out screening for this review come from different professional 1 backgrounds; this limits interpretation bias when assessing the studies to include. A recognised 2 assessment tool will be used to determine study quality. Using NVivo to code studies will aid 3 transparency in and demonstrate a clear strategy for identifying themes. An audit trail will be kept 4 throughout the systematic review detailing research decisions made and methodological steps 5 taken. 6
The results from this review will be published and made publically available. A number of social 7 media techniques (Twitter, Facebook) will be used to promote the protocol, final systematic review 8 paper and results. We will also aim to attend at least one conference to present findings from this 9 work. 10 11 12 12 List and define all variables for which data will be sought (such as PICO items, funding sources), any pre-planned data assumptions and simplifications
Pg 5 Lines 4-8 (inc table) Outcomes and prioritization
13 List and define all outcomes for which data will be sought, including prioritization of main and additional outcomes, with rationale Pg 3 Lines 15-19
Risk of bias in individual studies
14 Describe anticipated methods for assessing risk of bias of individual studies, including whether this will be done at the outcome or study level, or both; state how this information will be used in data synthesis
Pg 5 Lines 9-15
Data synthesis 15a Describe criteria under which study data will be quantitatively synthesised n/a 15b If data are appropriate for quantitative synthesis, describe planned summary measures, methods of handling data and methods of combining data from studies, including any planned exploration of consistency (such as I 2 , Kendall's τ) n/a 15c Describe any proposed additional analyses (such as sensitivity or subgroup analyses, meta-regression) n/a 15d If quantitative synthesis is not appropriate, describe the type of summary planned n/a Meta-bias(es)
16 Specify any planned assessment of meta-bias(es) (such as publication bias across studies, selective reporting within studies) Pg 5 Lines 14-15 Confidence in cumulative evidence 17 Describe how the strength of the body of evidence will be assessed (such as GRADE)
Pg 5 Lines 9-15 * It is strongly recommended that this checklist be read in conjunction with the PRISMA-P Explanation and Elaboration (cite when available) for important clarification on the items. Amendments to a review protocol should be tracked and dated. The copyright for PRISMA-P (including checklist) is held by the PRISMA-P Group and is distributed under a Creative Commons Attribution Licence 4.0. 
Methods and Analysis
14
We will search MEDLINE (Ovid), EMBASE (Ovid), and CINAHL for studies describing human factors 15 affecting both failure to rescue and/or care escalation. A search strategy was developed by two 16 researchers and a medical librarian. Only studies exploring in-hospital (ward) populations using 17 qualitative data collection methods will be included. Screening will be conducted by two researchers 18 from different professional backgrounds. We are likely to undertake a thematic synthesis, using the 19 Thomas and Harden framework. Selected studies will be assessed for quality, rigor and limitations. 20
Two researchers will extract and thematically synthesise codes using a piloted data extraction tool to 21 develop analytical themes.
22
Ethics and dissemination 23 The qualitative evidence synthesis will use available published literature and no ethical approval is 24 required. This synthesis will be limited by the quality of studies, rigor and reproducibility of study 25 findings. This publication will synthesise what is known about human factors and escalation of care, 26 highlighting gaps within the literature. Results will be published in a peer-reviewed journal, 27 publicised at conferences and on social media. Literature search strategies will be developed using Medical Subject Headings (MeSH) and text 29 words related to the human factors involved in the escalation of care for deteriorating patients.
28
TRIAL REGISTRATION
30
The following databases will be searched: MEDLINE (Ovid), EMBASE (Ovid), and CINAHL.
31
Reference lists of eligible studies and relevant reviews will be explored to identify further eligible 32 studies.
33
Search strategy
34
A draft of the search strategy was developed by three of the authors (JE, VW and TP). The proposed 35 search strategy is shown in the online Supplementary File 1. and/or discourse analysis. We will also include grey literature. All studies meeting inclusion criteria 7 will be included and reviewed.
36
Inclusion Criteria
8
Study focus 9
Studies must report primary data and describe human factors affecting failure to rescue and 10 escalation of care. Failure to rescue is defined as patient mortality following complications (1) and 11 escalation of care is a staged process where patients are identified as 'deteriorating', and that 12 deterioration is then communicated followed by senior review and medical intervention where 13 necessary (4). We will include any qualitative study which explores the perspective of patients or 14 clinical staff (adults or paediatric) and the human factors which affect the escalation of care process. 15 We are defining human factors as any barrier or facilitator that affects teamwork, tasks, equipment, 16 workspace, culture, or organisation (15).
17
The study setting is in-hospital, ward care.
19
Exclusion criteria
20
Types of studies 21
We will exclude systematic reviews, editorials, letters, practice guidelines and abstract-only reports. 22
We will also exclude protocols without study data. 23
Phenomenon of interest 24 We are only interested in real-life scenarios where human factors effects can be studied in the 25 patient environment. Simulation based studies will be excluded.
26
Setting 27
We will exclude studies carried out in the Emergency Department, Critical Care (including the 28
Intensive Care Unit and Coronary care) or Maternity. These are specialised areas which makes it 29 challenging to generalise to the ward environment any 'escalation of care' practices identified in 30 these areas. We will also exclude studies set in palliative care.
31
Time-frame 32
No time limitations will be applied 33 Language 34
Non-English papers will be excluded.
35
Study selection
36
Reference lists from all databases will be entered into Covidence software (Covidence systematic 37 review software, Veritas Health Innovation, Melbourne, Australia. Available at www.covidence.org). 38
Papers will be de-duplicated. Two authors will independently screen titles and abstracts of identified 39 papers against the inclusion and exclusion criteria. They will not be blinded to journal titles, study 40 authors or institutions. If there is disagreement or uncertainty regarding eligibility, the full-text will 41 be reviewed. We will retrieve full-text for all articles not excluded by the initial screening. Two 42 authors will independently assess these papers against the inclusion and exclusion criteria outlined 43 above. We will resolve disagreements about eligibility by discussion between the screening 44 researchers or a third party. We will record the reason for excluding studies. independently extract a selection data from the texts to ensure validity of results. Any discrepancies 6 within the data collection phase will be resolved by discussion between reviewers or a third party.
7
Data items extracted 8
We will extract the following data from each included publication (refer to Table. 1 for full data 9 details). The data extraction method has been piloted with a sample selection of papers and valid 10 data have been obtained.
11 Table 1 -Anticipated data to be extracted
Quality Assessment
14
The CASP qualitative checklist (Critical Appraisal Skills Programme) will be used to assess credibility, 15 transferability, dependability and confirmability. This checklist is an extensive and comprehensive 16 tool commonly used in qualitative study assessment (16,17). As part of the CASP assessment the 17 authors will explore the potential for reporting bias within the studies and biases will be reported in 18 studies' limitations. We will also apply the Confidence in the Evidence from Reviews of Qualitative 19 research (GRADE-CERQual) criteria to judge studies (18). Two researchers will discuss each study and 20 a consensus will be reached to include or exclude.
21
Data Analysis
22
This review aims to explore relevant theory and map barriers and facilitators to escalation of care for 23 which thematic synthesis is well suited (17). We are likely to undertake a thematic synthesis, using 24 the Thomas and Harden framework (19). This framework supports data extraction from anywhere 25 within the paper, and is not confined to the results alone. factors and escalation of care will be identified from anywhere within the papers, and tables will be 5 used to record descriptive and analytical themes. Key codes, descriptive themes and analytical 6 themes will be presented in the results. We will use the enhancing transparency in reporting the 7 synthesis of qualitative research (ENTREQ) guidelines to report findings (21).
8
Patient and Public Involvement (PPI)
9
A patient representative has read and provided feedback on the protocol. As a result, some points 10 have been clarified and medical "jargon" removed.
12
Ethics and dissemination
13
The proposed evidence synthesis will use published literature and therefore no ethical approval is 14 required. This publication will be limited by the quality of studies available and the rigor and 15 reproducibility of study findings. Original studies included in the review could themselves be limited 16
and it may be difficult to assess the researcher involvement and their individual bias. The two 17 researchers carrying out screening for this review come from different professional backgrounds, 18 limiting interpretation bias when assessing the studies for inclusion. A recognised assessment tool 19 will be used to determine study quality. Using NVivo to code studies will aid transparency and 20 demonstrate a clear strategy for theme identification. An audit trail kept throughout the process, 21
will detail decisions made and methodological steps taken.
22
The results from this review will be published and made freely available. A number of social media 23 techniques (including Twitter, Facebook, and our research group website) will be used to promote 24 the protocol, final paper and results. We will also aim to attend at least one conference to present 25 findings from this work. 36. "human error* ".af.
27
37. "clinical error* ".af.
38. "medical error* ".af.
39. "protocol adherence".af.
40. "protocol compliance".af.
41. "teamwork*".af.
communication.af.
43. ("socio cultural" or sociocultural).af.
44. "situation awareness".af.
45. "organisational culture".af.
46. "organizational culture".af.
47. "safety culture".af.
48. "patient safety".af. Selection process 11b State the process that will be used for selecting studies (such as two independent reviewers) through each phase of the review (that is, screening, eligibility and inclusion in meta-analysis)
Pg 4 Lines 38-44
Data collection process 11c Describe planned method of extracting data from reports (such as piloting forms, done independently, in duplicate), any processes for obtaining and confirming data from investigators
Pg 5 Lines 2-6
Data items 12 List and define all variables for which data will be sought (such as PICO items, funding sources), any pre-planned data assumptions and simplifications
Pg 4 Lines 7-10(inc table) Outcomes and prioritization 13 List and define all outcomes for which data will be sought, including prioritization of main and additional outcomes, with rationale Pg 4 Lines 9-10
Risk of bias in individual studies
14 Describe anticipated methods for assessing risk of bias of individual studies, including whether this will be done at the outcome or study level, or both; state how this information will be used in data synthesis 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 Outcomes and Death and National Institute of Clinical Excellence CG 50 highlight failure to rescue as 6 a significant problem for safe patient care.
7
To avoid failure to rescue events, there must be successful escalation of care. Studies indicate that 8 human factors such as situational awareness, team working, communication, and a culture 9 promoting safety contribute to avoidance of failure to rescue events. Understanding human factors 10 is essential to developing work-systems that mitigate barriers and facilitate prompt escalation of 11 care. This qualitative evidence synthesis will identify and synthesise what is known about the human 12 factors that affect escalation of care.
13
Methods and Analysis
14
We will search MEDLINE (Ovid), EMBASE (Ovid), and CINAHL, between database inception and 2018, 15
for studies describing human factors affecting failure to rescue and/or care escalation. A search 16 strategy was developed by two researchers and a medical librarian. Only studies exploring in-17 hospital (ward) populations using qualitative data collection methods will be included. Screening will 18 be conducted by two researchers. We are likely to undertake a thematic synthesis, using the Thomas 19 and Harden framework. Selected studies will be assessed for quality, rigor and limitations. Two 20 researchers will extract and thematically synthesise codes using a piloted data extraction tool to 21 develop analytical themes.
22
Ethics and dissemination
23
The qualitative evidence synthesis will use available published literature and no ethical approval is 24 required. This synthesis will be limited by the quality of studies, rigor and reproducibility of study 25 findings. Results will be published in a peer-reviewed journal, publicised at conferences and on social 26 media. 2 Failure to rescue is defined as the mortality rate of patients who suffer complications in hospital (1). 3
27
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The incidence of failure to rescue events varies between hospitals but has been estimated as 10.9% 4 in high-volume hospitals and 13.3% in low-volume hospitals (2) . A proportion of patient deaths 5 (32%) reported to the National Patient Safety Agency (NSPA) had failures surrounding diagnostic 6 errors and deteriorations which were not adequately recognised (3). Failure to recognise the need to 7 rescue patients by providing timely escalation of care is a finding in several national reports such as 8 National Confidential Enquiry into Patient Outcomes and Death (NCEPOD) (4-7) and NICE CG 50 (8).
9 For 'failure to rescue' to be avoided, bedside clinical staff must usually initiate successful escalation 10 of care (9). This staged process requires detection of deterioration, communication about 11 deterioration, and medical actions following senior review (4). Many factors affect this process such 12 as situational awareness, team working, communication, safety culture and leadership (4,10-14). 13
Understanding these human factors is essential to developing working systems that mitigate barriers 14 and facilitate prompt escalation of care.
15
The aim of this qualitative evidence synthesis is to map the human factors which affect escalation of 16 care in the acute hospital setting. It will summarise what is currently understood about the role 17 human factors play in the delivery of clinical care. Secondly, it will identify gaps in the current 18 literature and establish strengths and weaknesses of research conducted to date. This will produce 19 an evidence base from which escalation of care theory could be developed. We will also identify 20 potential areas for further research in human factors and the escalation of care process.
22
Methods and Analysis
Registration
24
This protocol adheres to the requirements of Preferred reporting items for systematic review and 25 meta-analysis protocols (PRISMA-P). The protocol was registered with PROSPERO (ref:  26  CRD42018104745) 27
Information sources
28
Literature search strategies will be developed using Medical Subject Headings (MeSH) and text 29 words related to the human factors involved in the escalation of care for deteriorating patients.
30
The following databases will be searched: MEDLINE (Ovid), EMBASE (Ovid), and CINAHL. Dates 31 searched will be from database inception to January 2018.
32
Reference lists of eligible studies and relevant reviews will be explored to identify further eligible 33 studies. and/or discourse analysis. We will also include grey literature. All studies meeting inclusion criteria 7 will be included and reviewed.
Study focus 9
Studies must report primary data and describe human factors affecting failure to rescue and 10 escalation of care. Failure to rescue is defined as patient mortality following complications (1) and 11 escalation of care is a staged process where patients are identified as 'deteriorating', and that 12 deterioration is then communicated followed by senior review and medical intervention where 13 necessary (4). We will include any qualitative study which explores the perspective of patients or 14 clinical staff (adults or paediatric) and the human factors which affect the escalation of care process. 15
We are defining human factors as any barrier or facilitator that affects teamwork, tasks, equipment, 16 workspace, culture, or organisation (15).
19
Exclusion criteria
20
26
Setting 27
31
Time-frame 32
35
Study selection
36
Reference lists from all databases will be entered into Covidence software (Covidence systematic  37 review software, Veritas Health Innovation, Melbourne, Australia. Available at www.covidence.org). 38
Papers will be de-duplicated. Two authors will independently screen titles and abstracts of identified 39 papers against the inclusion and exclusion criteria. They will not be blinded to journal titles, study 40 authors or institutions. If there is disagreement or uncertainty regarding eligibility, the full-text will 41 be reviewed. We will retrieve full-text for all articles not excluded by the initial screening. Two 42 authors will independently assess these papers against the inclusion and exclusion criteria outlined 43 above. Papers which inclusion is uncertain, will be fully reviewed for synthesis suitability. We will independently extract a selection data from the texts to ensure validity of results. Any discrepancies 8 within the data collection phase will be resolved by discussion between reviewers or a third party.
9
Data items extracted 10
We will extract the following data from each included publication (refer to Table. 1 for full data 11 details). The data extraction method has been piloted with a sample selection of papers and valid 12 data have been obtained. 
16
The CASP qualitative checklist (Critical Appraisal Skills Programme) will be used to assess credibility, 17 transferability, dependability and confirmability. This checklist is an extensive and comprehensive 18 tool commonly used in qualitative study assessment (16,17). As part of the CASP assessment the 19 authors will explore the potential for reporting bias within the studies and biases will be reported in 20 studies' limitations. Two researchers will discuss each study and a consensus will be reached to 21 include or exclude.
22
Assessment of confidence in synthesised findings
23
We will apply the Confidence in the Evidence from Reviews of Qualitative research (GRADE-CERQual) 24 criteria to judge confidence in synthesised findings (18). We will apply the CERQual criteria to each 25 study finding, assessing for methodological limitations, relevance, coherence and adequacy of data. 26 This method will generate a Summary of Qualitative of Study Findings (SoQF) table, providing a 27 transparent method with which to assess included studies and results (18). 'going beyond' the findings of the initial study, which relate to the fixed or emerging research 10 question. Whilst we have been explicit at this point as to the anticipated framework, it is also 11 justifiable for this to change once the search has been conducted (20).
28
Data Analysis
12 NVivo software will be used to code the original text from papers. Using this software will facilitate 13 analysis for this evidence synthesis and will be used to record decisions (by audit trail) of coding. 14 Codes relating to human factors and escalation of care will be identified from anywhere within the 15 papers, and tables will be used to record descriptive and analytical themes. Key codes, descriptive 16 themes and analytical themes will be presented in the results. We will use the enhancing 17 transparency in reporting the synthesis of qualitative research (ENTREQ) guidelines to report 18 findings (21).
19
Patient and Public Involvement (PPI)
20
A patient representative (TD) has read and provided feedback on the protocol. As a result, some 21 points have been clarified and medical "jargon" removed.
23
Ethics and dissemination 24 The proposed evidence synthesis will use published literature and therefore no ethical approval is 25 required. This publication will be limited by the quality of studies available and the rigor and 26 reproducibility of study findings. Original studies included in the review could themselves be limited 27
and it may be difficult to assess the researcher involvement and their individual bias. The two 28 researchers carrying out screening for this review come from different professional backgrounds, 29 limiting interpretation bias when assessing the studies for inclusion. A recognised assessment tool 30 will be used to determine study quality. Using NVivo to code studies will aid transparency and 31 demonstrate a clear strategy for theme identification. An audit trail kept throughout the process, 32 will detail decisions made and methodological steps taken.
33
The results from this review will be published and made freely available. A number of social media 34 techniques (including Twitter, Facebook, and our research group website) will be used to promote 35 the protocol, final paper and results. We will also aim to attend at least one conference to present 36 findings from this work. 36. "human error* ".af.
38
42. communication.af.
48. "patient safety".af. 11b State the process that will be used for selecting studies (such as two independent reviewers) through each phase of the review (that is, screening, eligibility and inclusion in meta-analysis)
Pg 4 Lines 38-44
Pg 5 Lines 4-12
Pg 4 Lines 7-10(inc table) Outcomes and prioritization 13 List and define all outcomes for which data will be sought, including prioritization of main and additional outcomes, with rationale Pg 4 Lines 9-10 Risk of bias in individual studies 14 Describe anticipated methods for assessing risk of bias of individual studies, including whether this will be done at the outcome or study level, or both; state how this information will be used in data synthesis
Pg 5 Lines 15-28
Data synthesis 15a Describe criteria under which study data will be quantitatively synthesised n/a 15b If data are appropriate for quantitative synthesis, describe planned summary measures, methods of handling data and methods of combining data from studies, including any planned exploration of consistency (such as I 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46 
